Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADM Tronics Secures Third Patent On Medical Device for Treatment of Neuro-Cerebral Disorders.


Business Editors/Health & Medical Writers

NORTHVALE, N.J.--(BUSINESS WIRE)--Dec. 1, 2000

The US Patent Office has issued a third patent on a non-invasive medical device for treating neuro-cerebral disorders, such as multiple sclerosis and Parkinson's disease, developed at ADM See add/drop multiplexer.

(language) ADM - A picture query language, extension of Sequel2.

["An Image-Oriented Database System", Y. Takao et al, in Database Techniques for Pictorial Applications, A. Blaser ed, pp. 527-538].
 Tronics Unlimited, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
 - ADMT ADMT Active Directory Migration Tool
ADMT Air Dry Metric Ton
ADMT Automated Data Management Tool
).

The new patent entitled, "Corona Discharge Beam Treatment of Neuro-Cerebral Disorders" further covers a therapeutic electronic medical device that non-invasively treats a patient's neuro-cerebral condition with a pulsatory pul·sa·to·ry  
adj.
Having rhythmical vibration or movement.
 corona discharge of a complex electronic energy signal.

The technology covered by the three patents, called "NCCD NCCD National Council on Crime and Delinquency
NCCD National Calamity Contingent Duty
NCCD Nuclear Command and Control Document
NCCD National Council of Clinical Directors
" for Neuro-Cerebral Corona Discharge, was invented by Dr. Alfonso Di Mino, President and founder of ADM Tronics and Andre' Di Mino, Executive Vice President. The patents have been assigned to ADM Tronics. "I am pleased that we have another patent for the NCCD," stated Dr. Di Mino. "I hope that it will soon be able to help many people suffering from neuro-cerebral disorders."

Initial limited clinical testing with the NCCD has been promising. However, ADM Tronics' management cautions that it believes widespread availability of this therapy is, at least, several years off. In addition to exploring clinical testing of the NCCD to assemble data for presentation to the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
, the Company is seeking strategic relationships to assist moving the technology through the clinical and regulatory process.

ADM Tronics is a technology based developer and manufacturer of a diversified line of products categorized into three distinct market segments - therapeutic, non-invasive electronic medical devices, environmentally safe chemical products and innovative topical dermatological products.

Statements contained in this release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such forward-looking statements are subject to risks and uncertainties (detailed in the Company's filings with the Securities and Exchange Commission) that could cause actual results to differ materially from estimated results.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 1, 2000
Words:307
Previous Article:Sherwin-Williams to Present At Salomon Smith Barney Chemical Conference.
Next Article:Third Sirius Satellite Radio Spacecraft Successfully Launched; Satellite is Third Built by Space Systems/Loral for New Nationwide Satellite-to-Car...
Topics:



Related Articles
MEDAREX/NEURO THERAPEUTICS TO DEVELOP ANTIBODY THERAPEUTICS.
MEDICURE GETS U.S. PATENT NOTICE OF ALLOWANCE FOR THERAPEUDICS.
SOMAXON EXERCISES OPTION TO LICENSE NALMEFENE.
All-purpose defoamer.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles